DJIA 15,973.84 313.66 2.00%
NASDAQ 4,337.51 70.68 1.66%
S&P 500 1,864.78 35.70 1.95%
market minute promo


13.06 0.27 (2.11%)

Quote as of

company name or ticker

Recent Quotes

INSM $13.06 2.11%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $12.96
Previous Close $12.79
Daily Range $12.44 - $13.10
52-Week Range $11.89 - $28.66
Market Cap $807.2M
P/E Ratio -6.91
Dividend (Yield) $0.00 (0.0%)
Volume 317,360
Average Daily Volume 544,344
Current FY EPS -$2.01




Drug Makers

INSMED, INC. (INSM) Description

A biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases, endocrine disorders and oncology within niche markets that have unmet medical needs. Website:

News & Commentary

This Week in Biotech: A Double-Dose of Hot Potato

Two pharma giants walk away from collaborations, another investigational drug receives the breakthrough designation, and more M&A activity are this week's biggest biotech stories.

Thursday 2/4 Insider Buying Report: PGR, INSM

Commit To Buy Insmed At $10, Earn 14.5% Using Options

Insmed's (INSM) CEO Will Lewis on Q3 2015 Results - Earnings Call Transcript

Insmed (INSM) Q3 2015 Results - Earnings Call Webcast

H.C. Wainwright: Time To Buy Insmed

Leerink Chats With Biotech Management, Names 20 Stocks To Buy Now

Oversold Conditions For Insmed

Use Options For a Chance To Buy INSM at a 55% Discount

Insmed's (INSM) CEO Will Lewis on Q2 2015 Results - Earnings Call Transcript

Insmed (INSM) Q2 2015 Results - Earnings Call Webcast

See More INSM News...

INSM's Top Competitors

INSM $13.06 (2.11%)
Current stock: INSM
AMGN $144.72 (2.30%)
Current stock: AMGN
GILD $89.44 (2.38%)
Current stock: GILD
BIIB $247.22 (0.86%)
Current stock: BIIB